The human immunodeficiency viruses (HIVs)
viability of these cells. However, in the presence of the antiherpetic nucleoside analog ganciclovir, Ad-tk infection resulted in a massive reduction in the viability of these Tat-expressing cell lines. As adenoviruses are natural passengers of the human lymphoid system, our results suggest adenovirus vector-based strategies for the targeted expression, under the control of cis-responsive HIV regulatory elements, of cytotoxic agents in HIV-infected cells for the therapy of HIV-mediated pathogenesis.
The human immunodeficiency viruses (HIVs) have been identified as the etiological agents of the acquired immunodeficiency syndrome (AIDS) (1, 2) and its associated disorders. HIV exhibits a tropism for CD4+ T lymphocytes, which constitute the primary target for HIV infection in vivo. Initial infections appear to be latent and are characterized by an extended, asymptomatic stage of pathogenesis. Disease progression results in a state of prolific viral replication that eventually leads to the massive depletion of CD4' T lymphocytes that occurs during AIDS (reviewed in refs. 3 and 4). Whereas substantial progress has been made on the molecular characterization of HIV, therapeutic treatment of HIVmediated pathogenesis has proved difficult, particularly due to uncertainties in understanding mechanisms relating to the persistence of viral latency.
Resting T lymphocytes are nonpermissive for HIV replication even though the virus efficiently binds to the CD4 receptor and is internalized. From this latent state, the virus can be initiated into productive infection by factors that activate quiescent CD4+ lymphocytes into cellular proliferation (5, 6 ). It appears that the latent provirus is activated by the same inducible cellular transcription factors that promote T-cell proliferation upon presentation of the appropriate antigen (reviewed in ref. 7) . This feature of HIV replication raises therapeutic possibilities; agents that are toxic to activated HIV-infected T cells would be expected to inhibit HIV replication and the ensuing pathogenesis.
Upon activation, HIV-infected T cells initiate a program of viral gene expression that is stringently controlled by two viral genes, tat and rev, whose products are nuclear regulatory proteins essential for viral replication. The product of the tat gene, Tat, functions predominantly by activating transcription from the viral 5' long terminal repeat (LTR) through a structured RNA target sequence, the transactivation response element (TAR); additionally, less prominent stimulatory effects on translation of TAR-containing mRNAs have also been ascribed to Tat (8) . The action of the rev gene product, Rev, is posttranscriptional; Rev selectively induces the nuclear export of a constitutively expressed pool of structural-gene mRNAs that contain a cis-acting sequence of extensive secondary structure, the Rev-responsive element (RRE) (7, 9) . The viral cis-acting sequences TAR and RRE, whose regulatory activity is tightly controlled by Tat and Rev, respectively, thus afford an excellent means for the targeted expression of cytotoxic agents in HIV-infected cells that express these regulatory proteins.
We report the development of an adenovirus vector-based "gene therapy" approach for the targeted expression of the conditionally cytotoxic herpes simplex virus type 1 thymidine kinase gene (HSV-1 tk) in cultured human cells expressing the HIV regulatory protein Tat. Whereas HSV-1 tk expression is not deleterious to mammalian cells, it can, unlike mammalian thymidine kinase, selectively phosphorylate certain nucleoside analogs to the monophosphate (10, 11) ; subsequently, the nucleoside monophosphate is converted by cellular phosphorylases to its triphosphate, whose incorporation into DNA by the cellular DNA polymerase a leads to inhibition of cellular DNA synthesis (12, 13) and eventual cell death, a process that has been termed "thymidine kinase obliteration" (TKO) (14, 15 Cell Transfection and S1 Nuclease Analysis of tk Expression. The regulation of expression of tk mRNA from pLtr-tk was examined in transient-expression assays by calcium phosphate-mediated transfection ofHeLa cells (3 x 105 per 60-mm dish) with 1 ,ug of pLtr-tk alone or along with 1 ,ug of pSV-Tat and/or 1 ,ug ofpSV-Rev. Forty-eight hours after transfection, cytoplasmic RNA was isolated and, after DNase I treatment, analyzed for tk and ,B-globin mRNA expression by Si nuclease protection using labeled DNA probes as described (22) . Si-digested products were analyzed by fractionation in 6% acrylamide/8 M urea gels. For analysis of tk mRNA, a Sph I-Kpn I probe 5' end-labeled at the Sph I site within the tk coding sequence in pLtr-tk was used. ,B-Globin mRNA was quantitated with a BamHI-Ssp I probe that was end-labeled at a BamHI site in pG2B and specific for the second exon of the rabbit G-globin gene. tk mRNA expression from plasmid pLtr-tkR was analyzed in the same manner as for pLtr-tk.
Analysis of tk Expression in Ad-tk-Infected Cells. HeLa or HeLa-tat cells (106) were infected with Ad-tk and/or d1309 at the indicated multiplicities of infection. Cytoplasmic RNA was isolated 16 hr after infection for S1 nuclease analysis of tk expression.
Assay of Ad-tk-Mediated Cytotoxicity. The cytotoxicity induced by the guanosine analog GCV (brand name Cytovene, Syntex Laboratories, Palo Alto, CA) in HeLa-tat or Jurkat-tat cells infected with Ad-tk was examined in a cell growth assay (14, 15) . HeLa-tat cells (2 x 104 per 60-mm dish) or Jurkat-tat cells (2 x 104 per ml) were infected with Ad-tk at 25 plaque-forming units (pfu) per cell and maintained in the presence of various concentrations of GCV. Uninfected cells were also maintained under identical conditions as controls for the evaluation ofGCV-mediated nonspecific cytotoxicity. After a total of 7 days for HeLa-tat cells and 10 days for Jurkat-tat cells, the inhibition of cell growth by Ad-tk at various concentrations of GCV was assayed by counting the viable cells, as determined by trypan blue exclusion, with a Neubauer hemocytometer. 
RESULTS
Strategy for Development of a Conditionally Cytotoxic Adenovirus Vector. An inducible HSV-1 tk gene was devised to explore whether the "thymidine kinase obliteration" technique (14, 15) could be exploited to confer conditional toxicity on human cells expressing the HIV regulatory proteins Tat and Rev. The efficacy of such a strategy in the therapy of HIV-mediated pathogenesis would ultimately rely on the targeted expression of tk in HIV-infected cells alone, so that uninfected cells could be spared.
A plasmid containing an inducible tk cassette (pLtr-tk, required for transcriptional activation by Tat, inclusive of TAR. Heterologous genes, when placed under the control of the HIV-1 LTR, exhibit barely detectable levels of expression when transfected into human cells; in the presence of Tat, expression of the heterologous proteins increases at least 100-fold from the combinatorial effects of Tat on transcription and translation (8) . To impose additional constraints on tk expression, a fragment (nucleotides 7201-8055 in the HIV-1 genome, strain HXB-3) containing the RRE (nucleotides 7201-7721; ref. 9) and the tat/rev 3' splice site was introduced downstream of the tk coding sequences with the expectation that tk mRNA expressed in the presence of Tat would be retained in the nucleus and would require coexpression of Rev for transport to the cytoplasm.
Since human adenoviruses ofgroup C, including Ad5, have been frequently isolated from tissues of lymphoid origin of healthy individuals (16) (Fig. 1B) . Ad-tk lacks most of the adenovirus El coding sequences and thus does not produce any of the multiple products of the ElA and E1B genes, including the ElA 289R protein that is essential for the trans-activation of other adenovirus early promoters and hence for viral replication in human cells (23) . Consequently, Ad-tk is replication-defective in human cells, a feature that increases its potential therapeutic value, since uncontrolled adenovirus multiplication in immunocompromised individuals can cause acute infections. Additionally, the ElA defect in Ad-tk also precludes any possible activation effects on the HIV LTR in HIV-infected cells, as it has been shown that the ElA 298R protein can trans-activate HIV-LTR expression (24, 25) .
Regulation of tk Expression by HIV Tat and Rev. The induction of expression of tk mRNA from pLtr-tk by the HIV regulatory genes tat and rev was examined in transientexpression assays by cotransfection of pLtr-tk with plasmids expressing HIV-1 Tat (pSV-Tat) or Rev (pSV-Rev) ( Fig. 2A). A B A plasmid (pG2B) expressing the rabbit A-globin gene was included in each transfection as a reference for normalizing transfection efficiencies. Cytoplasmic RNA was isolated for quantitation of tk mRNA expression by S1 nuclease analysis. In cells transfected with pLtr-tk alone (lane pUC13), tk expression was barely detectable. In contrast, in cells cotransfected with pLtr-tk and pSV-Tat, there was a 20-to 30-fold increase in tk expression as indicated by the appearance of a 170 bp Si-protected band corresponding to tk mRNA initiated at the correct transcription start site within the HIV-1 LTR. Coexpression of Rev did not augment Tat-mediated trans-activation of tk mRNA expression any further. In all transfections, a 209-bp 83-globin-specific fragment was protected at comparable levels, thereby suggesting that the variation in the levels of tk expression was not due to altered transfection efficiencies. As expected, a single tk mRNA species of -2.4 kilobases was detectable in all transfections by Northern blot analysis (data not shown). These results suggest that Tat induces a very pronounced increase in cytoplasmic tk mRNA levels expressed from the HIV LTR; as this level of cytoplasmic expression could not be increased by cotransfection of Rev, the HIV-1 genomic sequences between nucleotides 7201 and 8055 containing the RRE and the tat/rev 3' splice site appear to be insufficient to confer Rev-dependent regulation on tk expression.
The expression of the chimeric tk gene from the replication-defective recombinant adenovirus vector Ad-tk was then examined by infection of HeLa cells and HeLa cells expressing Tat (Fig. 2B) 25 pfu per cell and the infected cells were then maintained in culture medium containing various concentrations of GCV. As controls to monitor any nonspecific cytotoxic effects that might be mediated by drug treatment, uninfected cells were maintained under identical conditions. GCV treatment of uninfected cells appeared to be slightly toxic, with about 20% cell death occurring only at a relatively high (30 AM) concentration (Fig. 3A) .
The toxic effects of GCV on Ad-tk-infected HeLa-tat cells were dramatic, with >98% cell death occurring at 3 ,uM GCV; this was clearly a consequence of specific induction by GCV of toxicity to infected HeLa-tat cells, since even at 10 ,uM, GCV was not significantly toxic to uninfected HeLa-tat cells (Fig. 3A) . Moreover We next examined the ability of Ad-tk to induce conditional ablation of the Tat-expressing, transformed CD4' Tcell line Jurkat-tat in the above-described cell growth assay. An -75% reduction in cell viability was observed in Ad-tk infected Jurkat-tat cells at 10 AM GCV, at which concentration no non-specific toxic effects were manifested in uninfected cells (Fig. 3B) .
These results indicate that the expression of the I4SV-1 tk gene upon Ad-tk infection of human cells expressing HIV-1 Tat results in the development of a toxic phenotype in the presence of GCV with gross reductions occurring in the viability of such infected cells.
Conferral of a Rev-Responsive Phenotype on tk mRNA Expression. Rev-dependent regulation, in addition to involving the RRE, is also dependent on the recognition of splice sites in RNA (27) . Therefore, we investigated whether it might be possible to increase the specificity of HIV LTRdriven tk expression for HIV-infected cells by analyzing the expression of a chimeric HIV LTR-tk gene from a plasmid pLtr-tkR, which contains HIV-1 sequences inclusive of the tat/rev 5' splice site and the RRE cloned downstream of the tk coding region (see Materials and Methods). The modulation of tk mRNA expression from pLtr-tkR by Tat and Rev was examined in transient-expression assays in HeLa cells by S1 nuclease analysis of cytoplasmic RNA. Cells transfected with pLtr-tkR alone exhibited low levels of tk expression (Fig. 4, lane pUC13) These results suggest that an additional level of regulation could be imposed on the cytoplasmic expression of HSV-1 tk by the inclusion of cis-acting elements from the HIV genome that are responsive to Rev, thereby increasing the specificity of induction of tk-mediated toxicity to HIV-infected cells.
DISCUSSION
Current approaches directed at therapeutic intervention in HIV-mediated pathogenesis involve the administration of dideoxynucleoside analogs such as 3'-azido-3'-deoxythymidine (AZT, an inhibitor of reverse transcriptase) and/or immunomodulators such as interleukin 2 or interferon y and have had limited success. Although it is most likely that effective treatment of HIV-1 infection may depend upon a combination of approaches directed against various stages in the viral replicative cycle, an attractive modality for therapeutic intervention would be to eliminate the initial pool of infected T cells that acts as a reservoir for subsequent disease development. We have exploited human adenoviruses to develop a strategy that could be used for the targeted expression of cytotoxic genes in HIV-infected cells.
We have demonstrated that the replication-defective "suicide" adenovirus vector Ad-tk can, by selectively inducing high-level HSV-1 tk expression in human cells expressing HIV-1 Tat, lead to drastic reductions in the viability of such cells in the presence of the guanosine analog GCV. The toxic effects ofAd-tk were less severe on Jurkat cells than on HeLa cells at equal multiplicities of infection, probably because established lymphoblastoid cell lines, including Jurkat cells, are less efficient for adenovirus infection than are HeLa cells (26) . The extent of cytotoxicity mediated by GCV appears to be directly proportional to the level of cellular HSV-1 tk expression. In agreement with this observation, the severity of toxicity to Jurkat-tat cells was found to increase at higher multiplicities of infection with Ad-tk at the concentrations of GCV used in this study (data not shown).
Biochemistry: Venkatesh et al. I Another important outcome of our studies is the demonstrated feasibility of using HIV-1 cis-acting elements responsive to regulation by Tat for the targeted expression of cytotoxic agents in HIV-infected cells. Ad-tk-mediated induction of tk mRNA expression from the HIV LTR in HeLa-tat cells was at least 30-to 40-fold higher than in HeLa cells, thereby permitting the choice of physiologically relevant GCV concentrations (immunosuppressed individuals undergoing GCV treatment for cytomegalovirus retinitis exhibit peak plasma GCV concentrations of about 40 AM) to elicit toxic obliteration of Tat-expressing human cells with minimal manifestation of nonspecific cytotoxicity. Since it has been suggested that a number of heterologous agents may activate the HIV LTR in latent HIV-infected T cells by mechanisms independent of antigenic stimulation (7), the inclusion of an additional constraint on tk expression at the posttranscriptional level such as that afforded by Revdependent regulation would be expected to increase the specificity of tk-mediated toxicity for HIV-infected cells.
This might be especially useful in restricting the cell specificity of Ad-tk action, since adenovirus can infect a variety of human cell types. Contrary to our expectations, however, the non-spliceable tk transcript containing the RRE expressed by pLtr-tk was not subject to regulation by Rev. A key feature of Rev-dependent regulation involves the retention of RREcontaining transcripts within the nucleus in the absence of Rev; Rev expression results in the transport of such RNAs to the cytoplasm. The efficient expression from pLtr-tk of RRE-containing tk-mRNA in the cytoplasm of transfected cells in the presence of Tat suggests that the mere inclusion of the HIV region containing the RRE in tk mRNA is not sufficient for regulation by Rev. This observation is supported by a study (27) suggesting that regulation by Rev, in addition to involving the RRE, is also dependent on the presence of the HIV tatlrev 5' and/or 3' splice sites in RNA.
The tk mRNA expressed from pLtr-tk contains, in addition to the RRE, the tat/rev 3' splice site, suggesting that these two RNA elements are not sufficient to confer Rev regulation on tk expression. It appears that the tat/rev 5' splice site may be an important component of Rev function, much in the manner described for the 5' splice site in the regulation of human T-lymphotropic virus type I gene expression by the functionally homologous Rex protein (28) . The dependence of tk mRNA expression directed by pLtr-tkR on Rev for maximal cytoplasmic accumulation suggests that this might indeed be the case. The absence of a complete dependence on Rev coexpression for cytoplasmic expression of tk from pLtr-tkR may reflect a requirement for additional cis-acting information from the HIV env region for stringent Rev-dependent regulation. In principle, these HIV cis-acting elements could also be used for the stringently regulated expression of toxins such as ricin A chain and Pseudomonas exotoxin A in HIV-infected cells. Current approaches for the delivery of such potent toxins selectively to HIV-infected cells in vitro (29, 30) are dependent on conjugation to the cell surface protein CD4 (which binds to the H4V-encoded plasma membrane envelope protein gp120), a strategy that is somewhat limited in its application, as freely circulating gpl20 shed from HIV-infected cells may bind to CD4 of uninfected cells, thereby causing extensive nonspecific cytotoxicity.
Adenoviruses have well-characterized genomes, are easy to manipulate, and can be prepared in copious amounts at high titers and are thus suitable for use in somatic gene therapy. Specific strains of adenoviruses have been utilized to engineer vaccines for human use (31) . Adenoviruses have been frequently identified in peripheral blood lymphocytes from healthy individuals, and infections in immunocompetent humans are usually not associated with symptomatic disease. The demonstrated ability of adenoviruses to infect T cells in peripheral blood lymphocytes in vitro suggests possibilities for their use as vectors for the delivery of HIVinhibitory agents to infected cells in vivo. These features, coupled with the ability to package and express foreign genes, make human adenoviruses potential candidates for use as viral vectors in the "gene transfer" approach to therapeutic intervention in HIV-mediated pathogenesis.
